Literature DB >> 8357348

Ramipril prevents impaired endothelium-dependent relaxation in arteries from rabbits fed an atherogenic diet.

K M Finta1, M J Fischer, L Lee, D Gordon, B Pitt, R C Webb.   

Abstract

Endothelium-dependent relaxation in arteries is attenuated in clinical and experimental atherosclerosis. This study investigates the endothelial preservation properties of the angiotensin converting enzyme inhibitor, ramipril, by assessing its ability to restore endothelium-dependent responsiveness in blood vessels from rabbits fed an atherogenic diet (0.25% cholesterol; 3% coconut oil; 12 weeks). Seven rabbits fed the atherogenic diet received ramipril (3 mg/kg mixed into their food daily) and 6 rabbits were maintained on the atherogenic diet alone. Control rabbits (n = 6) were fed a standard diet and did not receive ramipril. At the end of the dietary intervention, the rabbits were killed and blood was collected for measurement of the lipid profile. The thoracic aorta was isolated and half was frozen for pathologic review while the other half was cut into rings and placed in a muscle bath for measurement of isometric force development. Dose response curves to phenylephrine (10(-9) to 10(-5) M) and angiotensin II (10(-10) to 3 x 10(-7) M) were completed. There was a minimal decrease in responsiveness to phenylephrine in vessels from rabbits eating the atherogenic diet compared with controls and no significant differences in the response to angiotensin II for any of the vessels. Following contraction by phenylephrine, acetylcholine (10(-9) to 10(-5) M) and nitroglycerin (10(-10) to 10(-5) M) dose response curves were completed. Relaxation to acetylcholine in aortic rings from control rabbits was observed, although in arteries from atherogenic rabbits relaxation was attenuated. This effect was prevented in the atherogenic rabbits fed ramipril. Responsiveness to the endothelium-independent vasodilator, nitroglycerin, was similar in arteries from the three rabbit groups.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8357348     DOI: 10.1016/0021-9150(93)90201-5

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  12 in total

Review 1.  Lipids and endothelium-dependent vasodilation--a review.

Authors:  Lars Lind
Journal:  Lipids       Date:  2002-01       Impact factor: 1.880

Review 2.  Angiotensin II and nitric oxide interaction.

Authors:  Marc de Gasparo
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

Review 3.  Overview of the relationship between ischemia and congestive heart failure.

Authors:  W J Remme
Journal:  Clin Cardiol       Date:  2000-07       Impact factor: 2.882

Review 4.  The anti-ischemic potential of angiotensin-converting enzyme inhibition: insights from the heart outcomes prevention evaluation trial.

Authors:  B Pitt
Journal:  Clin Cardiol       Date:  2000-07       Impact factor: 2.882

5.  Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.

Authors:  A Daugherty; M W Manning; L A Cassis
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

Review 6.  Bradykinin-mediated cardiovascular protective actions of ACE inhibitors. A new dimension in anti-ischaemic therapy?

Authors:  W J Remme
Journal:  Drugs       Date:  1997       Impact factor: 9.546

7.  Inhibitory effects of fluvastatin, a new HMG-CoA reductase inhibitor, on the increase in vascular ACE activity in cholesterol-fed rabbits.

Authors:  H Mitani; T Bandoh; J Ishikawa; M Kimura; T Totsuka; S Hayashi
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

8.  Effects of low-dose combination therapy with an angiotensin-converting enzyme inhibitor and a diuretic on flow-mediated vasodilation in hypertensive patients: a 6-month, single-center study.

Authors:  Cevad Sekuri; Ozgur Bayturan; Hakan Gocer; Talat Tavli; Ugur Kemal Tezcan
Journal:  Curr Ther Res Clin Exp       Date:  2003-11

9.  Ramipril prevents hypersensitivity to phenylephrine in aorta from streptozotocin-induced diabetic rats.

Authors:  P Murray; B Pitt; R C Webb
Journal:  Diabetologia       Date:  1994-07       Impact factor: 10.122

Review 10.  Ramipril. An updated review of its therapeutic use in essential hypertension and heart failure.

Authors:  J E Frampton; D H Peters
Journal:  Drugs       Date:  1995-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.